Advanced search
Publication Cover
Acta Cardiologica Volume 77, 2022 - Issue 4
Submit an article Journal homepage
153
Views
0
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Predictive models for adverse clinical outcomes in Chinese patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting

Jian-Yong Zhenga Department of Cardiology, Division of Cardiology and Cardiovascular Surgery, 6th Medical Center of PLA General Hospital, Beijing, ChinaView further author information
,
Yi Caoa Department of Cardiology, Division of Cardiology and Cardiovascular Surgery, 6th Medical Center of PLA General Hospital, Beijing, ChinaView further author information
,
Dong-Tao Lia Department of Cardiology, Division of Cardiology and Cardiovascular Surgery, 6th Medical Center of PLA General Hospital, Beijing, ChinaView further author information
,
Yi-Gang Qiua Department of Cardiology, Division of Cardiology and Cardiovascular Surgery, 6th Medical Center of PLA General Hospital, Beijing, ChinaView further author information
,
Li Zhaoa Department of Cardiology, Division of Cardiology and Cardiovascular Surgery, 6th Medical Center of PLA General Hospital, Beijing, ChinaView further author information
,
Zheng-Ming Xua Department of Cardiology, Division of Cardiology and Cardiovascular Surgery, 6th Medical Center of PLA General Hospital, Beijing, ChinaView further author information
,
Yi-Xiong Huanga Department of Cardiology, Division of Cardiology and Cardiovascular Surgery, 6th Medical Center of PLA General Hospital, Beijing, ChinaView further author information
,
Zhi-Bo Honga Department of Cardiology, Division of Cardiology and Cardiovascular Surgery, 6th Medical Center of PLA General Hospital, Beijing, ChinaView further author information
,
Tian-Chang Lia Department of Cardiology, Division of Cardiology and Cardiovascular Surgery, 6th Medical Center of PLA General Hospital, Beijing, ChinaView further author information
,
Yi-Da Tangb Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaView further author information
,
Cheng-Jun Guoc Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Zhi-Min Mad Department of Cardiology, Beijing Tongren Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Yong-Quan Wuc Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China;e Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information
&
Yu Chena Department of Cardiology, Division of Cardiology and Cardiovascular Surgery, 6th Medical Center of PLA General Hospital, Beijing, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 360-365 | Received 06 Mar 2021, Accepted 27 Jun 2021, Published online: 06 Aug 2021

References

  • Miura T, Miyashita Y, Motoki H, et al. Comparison of mid-term outcomes between patients with and without atrial fibrillation undergoing coronary stenting in the second-generation drug-eluting stent era: from the SHINANO registry. Cardiovasc Interv Ther. 2017;32(3):206–215.
  • Sutton NR, Seth M, Ruwende C, et al. Outcomes of patients with atrial fibrillation undergoing percutaneous coronary intervention. J Am Coll Cardiol. 2016;68(9):895–904.
  • Rohla M, Vennekate CK, Tentzeris I, et al. Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease. Int J Cardiol. 2015;184:108–114.
  • Bramlage P, Cuneo A, Zeymer U, et al. Prognosis of patients with atrial fibrillation undergoing percutaneous coronary intervention receiving drug eluting stents. Clin Res Cardiol. 2013;102(4):289–297.
  • Gao F, Zhou YJ, Wang ZJ, et al. Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation. Circ J. 2010;74(4):701–708.
  • Abe M, Masunaga N, Ishii M, et al. Current status of percutaneous coronary intervention in patients with atrial fibrillation: the Fushimi AF Registry. J Cardiol. 2020;75(5):513–520.
  • Zheng JY, Li DT, Chen Y, Tang YD, et al. Sex difference in clinical outcomes of Chinese patients with atrial fibrillation and coronary stenting according to age. Anatol J Cardiol. 2021;25:17–23.
  • Fauchier L, Lecoq C, Ancedy Y, et al. Evaluation of 5 prognostic scores for prediction of stroke, thromboembolic and coronary events, all-cause mortality, and major adverse cardiac events in patients with atrial fibrillation and coronary stenting. Am J Cardiol. 2016;118(5):700–707.
  • Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC). Eur Heart J. 2021;42(5):373–498.
  • Huo Y, Ho W. Renal insufficiency and clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a multi-centre study. J Peking Univ Health Sci. 2007;39:624–629.
  • Sambola A, Bueno H, Gordon B, et al. Worse 12-month prognosis in women with non-valvular atrial fibrillation undergoing percutaneous coronary intervention. Thromb Res. 2019;178:20–25.
  • Sun Y, Wang Y, Jiang J, et al. Renal dysfunction, CHADS2 score, and adherence to the anticoagulant treatment in nonvalvular atrial fibrillation. Clin Appl Thromb Hemost. 2017;23(3):248–254.
  • Jiang C, Lan DH, Du X, et al. Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: a report from the China atrial fibrillation registry study. J Cardiovasc Electrophysiol. 2019;30(12):2759–2766.
  • Ma C, Riou França L, Lu S, et al. Stroke prevention in atrial fibrillation changes after dabigatran availability in China: the GLORIA-AF registry. J Arrhythm. 2020;36(3):408–416.
  • Parfrey S, Teh AW, Roberts L, et al. The role of CHA2DS2-VASc score in evaluating patients with atrial fibrillation undergoing percutaneous coronary intervention. Coronary Artery Dis. 2021;32(4):288–294.
  • Borovac JA, Kwok CS, Mohamed MO, et al. The predictive value of CHA(2)DS(2)-VASc score on in-hospital death and adverse periprocedural events among patients with the acute coronary syndrome and atrial fibrillation who undergo percutaneous coronary intervention: a 10-year national inpatient sample (NIS) analysis. Cardiovasc Revasc Med. 2020;S1:553-8389(20)30472-3.
  • Aronson D, Edelman ER. Coronary artery disease and diabetes mellitus. Cardiol Clin. 2014;32(3):439–455.
  • Rosendorff C. Treatment: special conditions: co-existing heart disease: coronary artery disease, myocardial infarction, heart failure. J Am Soc Hypertens. 2015;9(8):651–654; quiz 5.
  • Lahtela HM, Kiviniemi TO, Puurunen MK, Schlitt A, et al. Renal impairment and prognosis of patients with atrial fibrillation undergoing coronary intervention – the AFCAS trial. PLOS One. 2015;10(6):e0128492.
  • Hiramoto JS, Katz R, Peralta CA, et al. Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2012;60(2):225–232.
  • Pisters R, Lane DA, Marin F, et al. Stroke and thromboembolism in atrial fibrillation. Circ J. 2012;76(10):2289–2304.
  • Kato ET, Giugliano RP, Ruff CT, et al. Efficacy and safety of edoxaban in elderly patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. JAHA. 2016;5(5):5.
  • Bronnum Nielsen P, Larsen TB, Gorst-Rasmussen A, et al. Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study. Chest. 2015;147(6):1651–1658.
  • Rubboli A, Schlitt A, Kiviniemi T, et al. One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry. Clin Cardiol. 2014;37(6):357–364.
  • Ruiz-Nodar JM, Marin F, Hurtado JA, et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. J Am Coll Cardiol. 2008;51(8):818–825.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.